Overview

A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study employs functional magnetic resonance imaging to compare brain activation patterns during a depressive episode in patients diagnosed with bipolar disorder, major depressive disorder, and a group of healthy control subjects. Depressed patients will be treated with a combination of fluoxetine and olanzapine and undergo MRI scans before, during, and after pharmacotherapy.
Phase:
Phase 4
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Eli Lilly and Company
Treatments:
Fluoxetine
Olanzapine